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The frequency of clinically evident renal tumors is increasing, due to an actual in-
crease in incidence, but also due to an improvement in detection methods. The aim 
of the present study was to analyze the incidence of renal tumors in an unselected 
autopsy series. A search for renal tumors was conducted based on the autopsy 
reports from the Department of Forensic Medicine. The slides were reviewed and 
reclassified according to current criteria. Among 14,904 autopsies, 80 renal tumors 
were found. The most frequent tumor types were clear cell carcinomas (41%), 
papillary carcinomas (18%) and cortical adenomas (19%). There were 66 males 
and 14 females. The average age was 57.83 for males and 62.86 for females. The 
characteristics of the study group were not exactly identical but similar to other 
autopsy series, and significantly different from surgical series.
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Introduction
Renal cell tumors have gained considerable interest 
in recent years. This is due to better understanding 
of their molecular pathogenesis which has resulted in 
the development of new strategies of treatment, par-
ticularly the use of targeted drugs. Worldwide, renal 
cell carcinoma is on the 14th place among the most 
frequent cancers (11th in males, 15th in females) [1]. 
The incidence in developed countries is higher, and 
it is considered the most deadly urologic malignancy. 
For the USA, the incidence is 20.7/100 000 in males 
and 10.5 in females. A 5-year survival rate is 70% 
[2]. In Poland the incidence is 10.0 in males and 5.4 
in females [3]. Interestingly, in most series there is 
a stepwise increase in incidence, although this trend 
seems to have reversed in the last few years, at least 
in some countries. The reasons for the changes in in-
cidence are unclear, as are the etiological factors for 
renal cell carcinoma; however changing trends in to-
bacco smoking may be one of the most important fac-
tors. Also, the increased incidence is accompanied by 
considerable stage migration. Indeed it was suggested 
that the incidence increases primarily in proportion to 
the detection of small tumors [4-8]. In particular the 
introduction and wide availability of ultrasonography 
resulted in a significant increase in renal tumor detec-
tion, as well as stage, grade and type migration [8]. 
Some interesting information about the epide-
miology of cancer may be obtained by analyzing 
post-mortem material. We previously reported inci-
dence of renal tumors in a series of hospital-derived 
autopsies [4]. The hospital population may however 
significantly differ from the general population. The 
forensic medicine departments may provide another 
source of autopsy material, giving further insight into 
the epidemiology of renal tumors.
Material and methods
The autopsy reports generated at the Department 
of Forensic Medicine between 1994 and 2008 were 
reviewed for the presence of any renal tumors; in 
such cases the original hematoxyllin and eosin stained 
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slides as well as paraffin blocks were retrieved and 
were reviewed by authors using a multiheaded mi-
croscope. The autopsy samples of renal tumors were 
fixed in formalin, routinely processed and paraffin 
embedded. From the paraffin blocks, 3 µm sections 
were prepared and stained by hematoxyllin and eosin 
by standard protocol. All the tumors were reclassi-
fied using standard criteria [9]. For dubious cases, 
the paraffin blocks were retrieved and new slides pre-
pared. If required for the classification, we used im-
munohistochemistry for pan-cytokeratin, cytokeratin 
7, high molecular weight cytokeratin, cytokeratin 
19, and epithelial membrane antigen performed by 
standard protocol; the primary antibodies are listed 
in the Table I. Briefly, the slides were dewaxed, re-
hydrated and incubated in 3% peroxide solution for 
10 minutes to block endogenous peroxidase activity. 
Antigen retrieval was carried out by microwaving in 
citrate buffer (0.2% citric acid titrated to pH 6.0 with 
2N NaOH) at 750W for 3 × 5 minutes. Primary an-
tibodies, all manufactured by DAKO, (DAKO, Den-
mark) are listed in Table I. The LabVision (Thermo 
Fisher Scientific, USA) detection system was used. 
3-amino-9-ethylcarbazole served as the chromogen. 
The slides were counterstained with Mayer’s hema-
toxylin (DAKO, Denmark).
The statistical analysis was performed with Statis-
tica 10 (StatSoft Inc., USA), using Pearson’s χ2 test, 
Mann-Whitney U test, Kruskal-Wallis ANOVA when 
appropriate. The significance level was set to 0.05.
Results
Between 1994 and 2008 a total of 14,904 post- 
mortem examinations were performed at the Depart-
ment of Forensic Medicine. In this material we found 
80 renal tumors, that is equal to 0.54% of the post- 
mortem examinations. The average age of the per-
sons with renal tumors was 58.73 years (range 21 to 
86, SD 13.53). There were 66 males and 14 females. 
The average age for males was 57.83 and 62.86 for 
females. The difference in age between genders was 
not statistically significant. The cause of death was 
violent in 54 cases (67.5%) and in 26 (32.5%) cases 
the death was unexpected, but it was due to medical 
reasons. There were no differences in age nor gender 
between these two groups of cases. Of 80 cases of renal 
tumors detected during autopsy, in 3 cases (3.75%) 
the tumor was metastatic from an extrarenal site. Of 
these, in one case the breast was the primary location, 
in one case the lung was the primary location, and 
in one case the primary location was uncertain. The 
most common histology among the primary tumors 
was clear cell (conventional) renal cell carcinoma, al-
though its frequency was significantly lower than in 
usual surgical series. Significantly, the overall number 
of papillary tumors, namely adenomas and papillary 
carcinomas, almost reached the number of clear cell 
carcinomas. The specific diagnoses are shown in Ta-
ble II, along with the average subjects’ age. The dif-
ferences in age of the patients with specific diagnoses 
were not statistically significant; of particular note is 
the quite similar age of the patients with the most 
prevalent histologic types (clear cell and papillary 
carcinoma, as well as renal adenoma). Somewhat sur-
prisingly, the ages observed in the current series were 
not dissimilar from the ones observed in our surgical 
material (60.9 for clear cell carcinoma, 59.7 for pap-
illary carcinoma, 60.0 for oncocytoma; unpublished 
data and [10-12]). There were some gender-related 
differences in the specific diagnoses: 30 out of 33 
subjects with clear cell carcinoma, 13 out of 14 with 
papillary carcinoma and 14 out of 15 with adenoma, 
were males, however all 3 cases of angiomyolipoma 
were observed in females. There were some differenc-
es in diagnoses between persons dying of violent or 
medical reasons (Table III), but these did not reach 
statistical significance.
Discussion
The methods to assess the real frequency of tumors 
may not be evident. Standard epidemiologic studies 
show only the incidence of symptomatic cases, and 
this may lead to biased results. Some tumors, such 
Table I. Primary antibodies used in the study
specificity clOne/type dilutiOn
CK-HMW 34βE12 1 : 50
CK7 OV-TL 12130 1 : 50
CK MNF116 1 : 50
CK19 RCK108 1 : 50
EMA E29 1 : 100
Table II. Diagnoses made in the study
diagnOsis n (%) age
clear cell carcinoma 33 (41.25%) 58.9
papillary carcinoma 14 (17.50%) 54.8
adenoma 15 (18.75%) 56.4
chromophobe carcinoma 1 (1.25%) 66
urothelial carcinoma 1 (1.25%) 75
oncocytoma 3 (3.75%) 76.7
unclassified carcinoma 6 (7.50%) 67.8
angiomyolipoma 3 (3.75%) 53.7
fibroma 1 (1.25%) 21
metastasis 3 (3.75%) 59.0
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as renal tumors, may tend to remain asymptomatic 
for long periods of time. In fact, currently most renal 
tumors are detected incidentally by imaging studies. 
The progress in accessibility and effectiveness of im-
aging may in part be responsible for the increased 
rate of detection of renal tumors. King et al. [13] an-
alyzed United States cancer registers for RCC cancer 
incidence, and found a continuous increase. Interest-
ingly the increase was most significant in a young-
er population; the increase was also more evident 
in females and concerned higher grade tumors. The 
authors explained this finding by increased obesity 
and tobacco smoking, which are both established 
risk factors. An unusual case is Sweden, where RCC 
frequency decreased since 1980. Lyrdal et al. showed 
that this is due to an actual decrease in incidence, fol-
lowed by decrease in stage and grade of the tumors. 
There were however no histologic tumor type migra-
tions [14]. The recognized phenomena are a decrease 
of stage and grade which are referred to as stage and 
grade migration, whereas the relative decrease of 
most aggressive histologic subtypes is referred to as 
type migration. Some interesting information about 
the epidemiology of cancer may be obtained from un-
selected autopsy material. Although anatomopatho-
logical autopsies are most frequently analyzed [4], it 
is difficult to regard them as entirely unselected; this 
is the why we decided to analyze forensic autopsies 
[7, 14-20].
Renal tumors are highly heterogeneous. The most 
frequent diagnostic categories include rather aggres-
sive conventional renal cell carcinomas, papillary carci-
nomas, indolent chromophobe carcinomas, and most 
benign oncocytomas. Also within these categories, 
individual tumors may differ greatly in their biologic 
potential and growth rate. This will result in differ-
ent odds of incidental detection versus symptomatic 
presentation. It is expected that the slowly growing 
and indolent tumors are likely to remain undetected 
along the patients’ life; the real frequency of such le-
sions could be assessed by autopsy studies only. We 
[4] and the others [7, 14, 16, 18, 20, 21] have shown 
previously that the relative frequency of conventional 
(clear cell) carcinomas is much lower in such materi-
al and the frequency of papillary tumors (carcinomas 
and papillomas) is much higher than in surgical se-
ries. Our previous study was biased in a way, as we 
considered anatomopathological post-mortem ma-
terial. The post-mortem examinations requested by 
the clinicians will obviously be performed on patients 
with primary conditions and causes of death that may 
influence the frequency of renal tumors (such as hy-
pertension, diabetes or smoking-related conditions). 
Consequently, the current anatomopathological post -
mortem examinations are becoming less represen-
tative of the entire hospitalized population. Even 
more importantly, we are experiencing a constant 
decrease in the rate of post-mortem examinations 
performed [22-24]. In our institution, the autopsy 
rate has dropped from 54.2% in 1979 to 15.3% in 
2009 (unpublished data); an even more drastic de-
crease is seen in other studies [22, 25]. With a de-
creased autopsy rate, the indication for them will also 
change. This undoubtedly influences the structure of 
the available population examined in different peri-
ods of time. On the other hand, the forensic autopsy 
rate seems to remain rather constant over time [22]. 
Also, the population of patients undergoing foren-
sic autopsies is different from the ones undergoing 
anatomopathogical autopsies, with an obvious over-
representation of younger people dying prematurely 
by a sudden or violent death. In fact, the average age 
in the current series was 58 years, over 10 years less 
than in our previous study [4]. Thus, forensic au-
topsy material should give us a unique insight into 
the frequency and category of the structure of re-
nal tumors, and this was the rationale behind the 
present study. In the present study, the frequency of 
renal tumors (0.54%) was much lower than in pre-
vious work (2.8%, p << 0.01). Also, the frequen-
cy of non-renal cancers was also significantly lower 
(30 vs. 3, p << 0.01). A potential limitation of the 
present approach might be limited interest for insig-
nificant medical lesions during forensic post-mortem 
examination. However, it may be assumed that by 
rule, all grossly visible renal lesions were sampled. 
Analysis of the frequencies of specific histological 
subtypes showed characteristics intermediate be-
tween our previous post-mortem and surgical series. 
In particular, the frequency of papillary adenomas 
was much lower than in anatomopathological autop-
sy cases. Papillary adenomas are interesting as they 
are thought to be a precursor lesion for papillary car-
cinoma [26].This could be due to the intrinsic dif-
ferences among forensic cases, as being younger may 
Table III. Diagnoses by cause of death
diagnOsis ViOlent sudden 
medical
clear cell carcinoma 25 (46.30%) 8 (30.77%)
papillary carcinoma 7 (12.96%) 7 (26.92%)
adenoma 12 (22.22%) 3 (11.54%)
chromophobe carcinoma 0 1 (3.85%)
urothelial carcinoma 1 (1.85%) 0
oncocytoma 2 (3.70%) 1 (3.85%)
unclassified carcinoma 3 (5.56%) 3 (11.54%)
angiomyolipoma 2 (3.70%) 1 (3.85%)
fibroma 1 (1.85%) 0
metastasis 1 (1.85%) 2 (7.69%)
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be less prone to have chronic renal disease; chronic 
renal disease is known to be related to appearance re-
nal adenomas [5]. Kihira et al. [18] detected 51 cas-
es of renal carcinomas in 7970 autopsies performed 
(0.65%). The rate seen in our present study is signifi-
cantly lower (0.54% renal tumors, but only 0.37% 
carcinomas). As the classification used by these au-
thors is outdated, it is difficult to comment on the 
histologic types described. Surprisingly, very large 
proportion of incidental renal cell carcinomas were 
accompanied by cancers in another location; we hav-
en’t seen such a phenomenon neither in this, nor our 
precedent study [4]. Mindrup et al. [25] analyzed 
frequency of renal tumors in two periods, 1955–60 
and 1991-2001. They found renal mass detection 
rate 3.4% and 2.3%, respectively, figures similar to 
our anatomopathologic material were reported in 
the precedent study [4]. While the overall number 
of renal tumors detected at autopsy decreased, the 
frequency of incidental renal carcinomas remained 
constant. Wunderlich et al. [20] analyzed frequency 
of necropsy-detected RCC in two Central-European 
regions, and found frequency of 1.76 and 1.55%, re-
spectively. They found certain increase in frequency 
of incidental RCC and this increase paralleled the 
increase in the clinically evident RCC. This lead to 
the conclusion that the increase of clinically-evident 
cancer is due to an actual increase in frequency, and 
not just to better detection. In Iceland, Jonsson et 
al. [21] found much lower frequency of autopsy – 
detected renal carcinoma (0.71%). In their material 
the tumors were smaller and lower stage than surgi-
cal cases. Similarly in our studies, the frequency of 
papillary tumors was significantly higher in autopsy 
cases (21% vs. 8%). Mauermann et al. [27] analyzed 
the gender differences in frequency of benign renal 
tumors, and in females found significantly higher 
incidence of angiomyolipoma, while oncocytomas 
were more frequent in males. Similarly in our study 
all angiomyolipoma patients were females, while 
2 out of 3 patients with oncocytoma were males. 
Of note, the diagnosis by imaging studies was be-
nign in only 17% of cases in Mauermann’s material. 
This is quite concerning, with a wider range of ther-
apeutic options available, and may lead to increased 
interest in renal mass biopsy [19].
In conclusion, we have found that the frequency 
and histopathological types of renal tumors in foren-
sic post mortem material are similar to that in anato-
mopathological post mortem material however some 
differences can be observed. 
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editing the manuscript. 
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